SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is experiencing heightened volatility and intense social media debate as investors weigh a massive post-IPO share unlock against the company's long-term growth prospects. The community is sharply divided between those bracing for a potential sell-off due to the influx of new supply and long-term supporters who view the dip as an opportunity to accumulate shares.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing significant market attention following a strong earnings report that featured record revenue, a guidance raise, and an improving path to profitability. The community is actively discussing the potential for a massive short squeeze, driven by the stock's high short interest and the anticipation of further growth from the pending LivePerson acquisition.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is trending as investors monitor the company's aggressive business development, including a $2.8 billion deal to acquire AtaiBeckley, aimed at diversifying its neuroscience portfolio beyond its dominance in the GLP-1 weight-loss and diabetes market. The community is actively debating the competitive pressure from Novo Nordisk's oral formulations and the sustainability of Lilly's premium valuation amidst ongoing legal battles over advertising claims.

Nintendo Co., Ltd. engages in the development, manufacture, and sale of home entertainment products. Its entertainment products include portable and console game machines and software, trump cards and Karuta (Japanese-style playing cards), multinational consumer electronics, home console hardware such as Nintendo Wii, Nintendo DS, Nintendo 3DS, as well as software for handheld and home console gaming machines. The company was founded by Fusajiro Yamauchi on September 23, 1889 and is headquartered in Kyoto, Japan.

Nintendo Co. Ltd - ADR

Nintendo is currently facing significant volatility as investors weigh strong hardware demand for the Switch 2 against cooling software sales and mounting input cost pressures from the semiconductor sector. The community remains deeply divided, with some betting on a long-term turnaround driven by the companys powerful intellectual property and entertainment expansion, while others are offloading shares due to concerns over compressed margins and weak forward guidance.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as investors rally behind significant platform validation from new partnerships with biotech giants Jazz and Vertex, fueling anticipation ahead of upcoming Phase 2 clinical data. The community is heavily focused on the potential of the ABCL635 readout as a key catalyst, sparking a surge in bullish sentiment and institutional interest despite the stock's long-term volatility.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin shares experienced a sharp decline following second-quarter results that missed revenue expectations and provided softer-than-anticipated guidance. While the company continues to demonstrate robust profit margins and remains a focal point for AI-driven advertising, the community is actively debating whether the current sell-off represents a temporary overreaction or a necessary valuation reset given elevated investor expectations.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is experiencing significant volatility and downward pressure as investors weigh concerns over project execution, margin compression, and institutional stake reductions against the company's massive backlog and exposure to the growing AI data center power demand. While some community members view the sharp price decline as a forced shakeout of leveraged positions and a potential long-term buying opportunity, others remain skeptical about the firm's ability to translate secured backlog into profitable earnings without a shift in management or operational strategy.

Investment Managers Series Trust II - Tradr 2X Long SNDK Daily ETF

Tradr 2X Long SNDK Daily ETF

The Tradr 2X Long SNDK Daily ETF ($SNXX) is seeing intense volatility and massive volume as traders speculate on SanDisks massive growth potential and upcoming earnings. The community is actively debating the impact of the company's significant stock buyback program, while momentum traders are closely tracking the ETF's aggressive price swings alongside the underlying stock's high-demand storage and memory chip sector.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is trending as investors aggressively position themselves ahead of the upcoming earnings report, with the community closely tracking potential margin improvements and international growth. While some investors fear further volatility due to heavy short interest and sector competition, many are viewing the current price as a key accumulation opportunity based on the brand's long-term market expansion.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors intensely scrutinize upcoming second-quarter earnings for signs of a turnaround, with sentiment heavily divided between those betting on Matrix-M platform licensing deals and those frustrated by a perceived lack of clear communication from management. Community discourse remains dominated by intense debate over the status of its respiratory vaccine collaborations and skepticism regarding current leadership.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TNL Mediagene and Totaligent Chart Paths in the Race to Reinvent Enterprise Marketing

Artificial intelligence is reshaping digital marketing, but not every company is pursuing the opportunity in the same way. Recent developments from TNL Mediagene (NASDAQ:TNMG) and Totaligent (OTCID:TGNT) illustrate two distinct strategies: one centered on enterprise AI services built atop an established media and consulting business, the other focused on developing an AI-powered marketing platform while broadening its strategic ambitions through acquisitions.

HAO Unveils Major AI Partnership, but TGNT is Better Option

AI continues to reshape digital advertising, and Haoxi Health Technology (NASDAQ:HAO) is positioning itself to capitalize on that trend through a new strategic cooperation agreement with NOVA MEDIA. The Beijing-based healthcare marketing specialist announced plans to jointly develop an AI-powered digital marketing system designed to automate content creation, streamline campaign execution, and enhance decision-making for healthcare advertisers across China's rapidly evolving online ecosystem.

AI, Biotech, And Healthcare Catalysts Drive Momentum

Several emerging public companies are attracting attention as artificial intelligence, healthcare innovation, medical technology, and international commercialization strategies continue converging across the market. From AI-powered drug discovery and regenerative medicine expansion to precision dermatology and medical device innovation, recent developments highlight how smaller companies are positioning themselves around some of the fastest-growing sectors in healthcare and technology. $TGNT, $NXTS, $AZTR, $ADTX, $TNON, $PFE

Biotech And AI Stocks Deliver Fresh Catalysts, as Investors Swarm into Growth Stories

Today's market action highlighted a familiar theme across the small-cap landscape: investors continue searching for transformative growth stories amid a market increasingly driven by company-specific catalysts. $TGNT, $TOVX, $MGNI, $PPCB, $MASK

AI Gold Rush and Global Healthcare Deals Erupt

Investor attention continues shifting toward companies positioned at the intersection of artificial intelligence, biotechnology, defense technology, healthcare infrastructure, and digital transformation. $TGNT, $NCRA, $FRSX, $VWAV, $WOK, $STTK

AI, Biologics, and Quantum Medicine Are Fueling a New Wave of Market Movers

Healthcare and biotechnology remain especially active and offer asymmetric upside potential, as companies pursue international expansion, strategic refinancing, AI-driven operational efficiency, and next-generation pharmaceutical technologies. $TGNT, $SPRC, $WGRX, $ATPC, $SNYR, $PHR

Innovation Igniting into High-Growth Spotlight

As capital continues flowing into high-growth sectors tied to artificial intelligence, biotechnology, diagnostics, and defense technology, several emerging companies are rapidly capturing investor attention through financings, acquisitions, regulatory approvals, and platform expansion strategies. $SBFM, $TGNT, $CODX, $JUNS, $VIDA, $QUCY, $GFS, $GOOG, $MSFT, $NVDA

Biotech and Biologics Break Out: These Tiny Stocks Are Suddenly Dominating the Market Conversation

Emerging biotech and biologics names exploded onto traders’ radar Wednesday as a wave of clinical milestones, regulatory momentum, strategic acquisitions, and high-volume technical breakouts fueled aggressive speculation across the sector. $HCWB, $TGNT, $KBLB, $SLS, $RKDA, $ROIV, $SLXN

Biologics Market Momentum Accelerates Across Healthcare, AI, And Global Medical Tourism

The biologics sector is rapidly emerging as one of the most closely watched growth stories in healthcare as breakthroughs in immunotherapy, regenerative medicine, cell engineering, and AI-assisted drug development continue reshaping investor sentiment. Unlike traditional pharmaceutical compounds, biologics leverage complex biological systems to target diseases with greater specificity, opening new opportunities in cancer, autoimmune disorders, rare diseases, and regenerative therapies. $HCWB, $TGNT, $MRNA, $REGN

Chasing the Next Explosive Small-Cap Run

Risk appetite came roaring back and several companies standing out, as market participants rotated heavily into sectors tied to transformative technologies and high-growth macro trends. $TGNT, $QUCY, $AEHL, $TDIC, $WGRX, $ERNA, $SLS, $WHWK

Totaligent, Inc. operates as a technology company, which provides AI-powered person-based digital marketing services for companies and individuals. The firm's digital marketing platform allows organizations to use and unlock owned and acquired data to market their products, services, and brands. Its platform leverages big data across multiple proprietary platforms including email, SMS, social media, programmatic advertising, short-code, and push notification to deliver micro-targeted person-based digital marketing and brand awareness for organizations, both large and small. The company was founded by Charles Bingham on June 24, 1988 and is headquartered in Boca Raton, FL.

Totaligent Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.0098
Prev Close	$0.0071
Open	$0.0095
Dividend Yield	0.00%
50-Day Moving Average	$0.0113
Beta	0.06
Avg. Volume	40,982.14
PE Ratio	-3.77

52-Week High	$0.056
52-Week Low	$0.0064
Market Capitalization	$2.57M
EPS (Annual)	-$0.0036
Price to Book	-0.94
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info